Patent EP0279986A1 successfully refreshed from Google Patents.
EP0279986A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Skin permeation enhancer compositions using glycerol monolaurate
Assignee: Alza Corp
•
Filing: 1987-12-08
•
Granted: —
•
Expires: 2007-12-08
Abstract
Abstract A method for enhancing the transdermal flux of a transdermally deliverable drug through intact skin is described in which the drug is delivered simultaneously with glycerol monolaurate. Preferred embodiments of therapeutic systems for delivering drug and glycerol monolaurate employ matrix containing drug at a concentration above saturation.
Inventors
- 👤 Yu-Ling Cheng
- 👤 Diane E. Nedberge
- 👤 Edna Sugihara
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-04 12:26
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7084; A61K47/00; A61K47/06; A61K47/08; A61K47/14; A61K9/0012; A61K9/0014
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
52 words
In a composition of matter for application to a body surface or membrane to deliver a biologically active agent by permeation through said body surface of membrane comprising a biologically active agent and a permeation enhancer therefor, the improvement wherein said permeation enhancer further comprises a permeation enhancing amount of glycerol monolaurate.
Claim 2
Dependent Claim
52 words
In a composition of matter for application to a body surface or membrane to deliver a biologically active agent by permeation through said body surface of membrane comprising a biologically active agent and a permeation enhancer therefor, the improvement wherein said permeation enhancer further comprises a permeation enhancing amount of glycerol monolaurate.
Claim 3
Dependent Claim
18 words
The composition of claim 1 wherein said agent and said permeation enhancer are dispersed within a carrier therefor.
Claim 4
Dependent Claim
22 words
The composition of claim 2 wherein said agent is present in an amount in excess of its saturation concentration in the carrier.
Claim 5
Dependent Claim
14 words
The composition of claim 1 wherein said body surface or membrane is intact skin.
Claim 6
Dependent Claim
34 words
The composition of claim 2, further comprising an occlusive backing behind the skin distal surface of said carrier; and means for maintaining said carrier in agent and permeation enhancer transferring relationship to intact skin.
Claim 7
Dependent Claim
19 words
The composition of claim 5 wherein said agent and said permeation enhancer are contained within a single reservoir means.
Claim 8
Dependent Claim
23 words
The composition of claim 6 wherein said agent is present in an amount in excess of its saturation concentration in said reservoir means.
Claim 9
Dependent Claim
18 words
The composition of claim 5 wherein said agent and said permeation enhancer are contained within separate reservoir means.
Claim 10
Dependent Claim
19 words
The composition of claim 8 wherein said agent is present in said reservoir means at a concentration above saturation.
References Cited (Backward Citations)
US3276933A
Cited
FR2276832A1
Cited
DE2631214A1
Cited
US4297353A
Cited
EP0152281A2
Cited
US4568343A
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.